{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "Innovus Pharma Enters $1 Billion Worldwide Nasal Steroid Market with the Acquisition of Fluticare(tm) (Fluticasone Propionate Nasal) over the Counter (\"otc\") Rights from Novalere",
    "author_name": "Innovus Pharmaceuticals, Inc.",
    "author_url": "http:\/\/www.innovuspharma.com\/index.php"
}